Hu et al. identified a 35-gene signature of overall survival in patients with 1p/19q codeleted tumors, highlighting pathways involving N-terminal acetyltransferases, protein acetylation, response to copper ions, prostaglandins, and inflammation, all of which may be involved in 1p/19q glioma progression [36]. The gene discussed is NAA15; the disease is central nervous system cancer.